FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Laura Santodonato

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Disorders

Procedures

Physiology

Devices

Gene Transfer Techniques

Co-author Network

Publications

TOP 3
Laura Lattanzi; Carmela Rozera; Diego Marescotti; Giuseppina D'Agostino; Laura Santodonato; Silvia Cellini; Filippo Belardelli; Riccardo Gavioli; Maria Ferrantini
IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.
Stefano M Santini; Caterina Lapenta; Laura Santodonato; Giuseppina D'Agostino; Filippo Belardelli; Maria Ferrantini
IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Laura Santodonato; Giuseppina D'Agostino; Roberto Nisini; Sabrina Mariotti; Domenica M Monque; Massimo Spada; Laura Lattanzi; Maria Paola Perrone; Mauro Andreotti; Filippo Belardelli; Maria Ferrantini
Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Laura Santodonato (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Laura Lattanzi; Carmela Rozera; Diego Marescotti; Giuseppina D'Agostino; Laura Santodonato; Silvia Cellini; Filippo Belardelli; Riccardo Gavioli; Maria Ferrantini
IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.
Immunobiology 2011;216(5):537-47.
2009: Stefano M Santini; Caterina Lapenta; Laura Santodonato; Giuseppina D'Agostino; Filippo Belardelli; Maria Ferrantini
IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Handbook of experimental pharmacology 2009;(188):295-317.
2003: Laura Santodonato; Giuseppina D'Agostino; Roberto Nisini; Sabrina Mariotti; Domenica M Monque; Massimo Spada; Laura Lattanzi; Maria Paola Perrone; Mauro Andreotti; Filippo Belardelli; Maria Ferrantini
Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(10):5195-202.
2002: Paola Matarrese; Luigi Di Biase; Laura Santodonato; Elisabetta Straface; Monica Mecchia; Barbara Ascione; Giorgio Parmiani; Filippo Belardelli; Maria Ferrantini; Walter Malorni
Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function.
The American journal of pathology 2002;160(4):1507-20.
2001: Laura Santodonato; Maria Ferrantini; Fabio Palombo; Luigi Aurisicchio; Paola Delmastro; Nicola La Monica; S Di Marco; Gennaro Ciliberto; MX Du; Milton Taylor; Filippo Belardelli
Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Cancer gene therapy 2001;8(1):63-72.
1999: Giuseppina D'Agostino; Eleonora Aricò; Laura Santodonato; Massimo Venditti; Paola Sestili; Laura Masuelli; Anna Coletti; Andrea Modesti; Gastón R Picchio; Donald E Mosier; Maria Ferrantini; Filippo Belardelli
Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(11):1305-16.
1997: Laura Santodonato; Giuseppina D'Agostino; Stefano M Santini; Davide Carlei; Piero Musiani; Andrea Modesti; P Signorelli; Filippo Belardelli; Maria Ferrantini
Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
Gene therapy 1997;4(11):1246-55.
1996: Laura Santodonato; Maria Ferrantini; L Gabriele; Enrico Proietti; Massimo Venditti; Piero Musiani; Andrea Modesti; Anna Modica; S D Lupton; Filippo Belardelli
Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir.
Human gene therapy 1996;7(1):1-10.
1995: L Gabriele; T Kaido; D Woodrow; J Moss; Maria Ferrantini; E Proletti; Laura Santodonato; Carmela Rozera; Chantal Maury; Filippo Belardelli
Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
The American journal of pathology 1995;147(2):445-60.
1993: Maria Ferrantini; Enrico Proietti; Laura Santodonato; L Gabriele; M Peretti; I Plavec; F Meyer; T Kaido; I Gresser; Filippo Belardelli
Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Cancer research 1993;53(5):1107-12.
1992: A Sala; I Gresser; D Chassoux; Chantal Maury; Laura Santodonato; Pierre Eid; M T Maunoury; Stefano Barca; Maurizio Cianfriglia; Filippo Belardelli
Inhibition of Friend leukemia cell visceral metastases by a new monoclonal antibody and role of the immune system of the host in its action.
Cancer research 1992;52(10):2880-9.
1991: A Sala; Arrigo Benedetto; G Elia; Simonetta Pulciani; C Ciotta; Eleonora Parlanti; Laura Santodonato; Filippo Belardelli
Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants.
Invasion & metastasis 1991;11(4):192-203.